Navigation Links
New Study: Life Science Jobs Total 77,000 in Washington State
Date:11/6/2009

SEATTLE, Nov. 6 /PRNewswire/ -- We Work for Health, an alliance of Washington state business, academic, government and community leaders, today released the results of a first-of-its-kind economic impact study showing that employment in Washington's life sciences sector has passed many of the traditional resource-based industries on which the state's economy was founded, and is in the same range of importance as some of the new, technology-based industries of the state.

Special Report: Washington Life Sciences Economic Impact Study, issued by the Washington Research Council and commissioned by We Work for Health Washington, details the local impact of a rapidly growing part of the world economy. In Washington state, life sciences is directly responsible for 22,349 jobs, indirectly resulting in roughly 55,000 additional jobs for a total of more than 77,000 jobs, according to the study.

Former Snohomish County Executive Bob Drewel presented the report to business, health care and elected leaders at the Washington Biotechnology and Biomedical Association's annual meeting.

"Very few people know just how important the life sciences are to the state's economy," said Drewel, a co-chair for We Work for Health Washington. "The reality is, and it is highlighted by this study, that the life sciences industry represents the future."

The report indicates demand for products and services generated by the life science industry can be expected to continue to grow rapidly in three principal areas: domestic healthcare, global health and sustainable biofuels.

The report also includes insightful breakdowns of investment and employment data by area and details the tendency of the life sciences industry to respond to clustering effects. While organizations representing nearly every aspect of the innovation pipeline are conducting important work in many parts of the state, the largest concentration of firms and institutions is located in Seattle, near the University of Washington.

The We Work for Health coalition, which is funded primarily by the biopharmaceutical industry, supports the growth of the life sciences sector, including biotechnology, biopharmaceutical and biomedical companies that develop innovative treatments to improve and save lives. In addition to improving the health and well-being of patients, the private companies and public institutions of Washington's life sciences sector play a critical role in the economic strength of Washington state.

Through world-renowned research and academic institutions, biopharmaceutical and biotechnology companies and global health organizations, Washington's life sciences industry has formed a unique innovation pipeline that creates high-paying jobs, drives economic activity, saves lives and defines Washington's cutting-edge business culture. Through investment in R&D and philanthropic grants to academic and community organizations, life sciences companies are an important source of innovation in the state.

For more information, please visit http://www.weworkforhealth.org/state/washington. To obtain a copy of Special Report: Washington Life Sciences Economic Impact Study, contact Jenna Kaluza, Nyhus Communications LLC for We Work for Health, (206) 323-3733 or jenna@nyhus.com.

About We Work For Health

We Work for Health unites organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers, key opinion leaders and the media about the economic impact of the life sciences innovation pipeline in Washington state. We Work for Health seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries and surrounding communities.

SOURCE We Work for Health


'/>"/>
SOURCE We Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. New study: Pine bark reduces perimenopausal symptoms
3. U of M study: Health food supplement may curb addiction of pathological gamblers
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
6. UGA study: Youth exposed to smokeless tobacco ads despite settlement
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Study: Modafinil is effective in treating excessive sleepiness
9. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
10. New study: pine bark extract boosts nitric oxide production
11. Study: HPV test beats Pap in detecting cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... , ... Getting earned media coverage meaningful for Garden Media Group's clients is ... year, Garden Media aims to provide material helpful to clients’ goals and bottom lines. ... key messages to gain coveted media placements, Garden Media wows clients year-round. , ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced today ... Allentown, Pennsylvania. This acquisition will add four additional processing facilities and a ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... , Mar 24, 2017 Research ... Therapy Manufacturing Market, 2017-2027" report to their offering. ... The Cell ... the rapidly growing market of cell therapy manufacturing and focuses ... manufacturing facilities. These therapies are anticipated to emerge as viable ...
Breaking Medicine Technology: